GSK Investigational Site

Saint-Pierre 97448

0 studies enrolling now · 6 studies all time

What they study most

Asthma, Hypertension, Pulmonary, Pulmonary Disease, Chronic Obstructive

Studies at this site

• MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects — Completed
• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma — Completed
• Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma — Completed
• 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease — Completed
• Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma — Completed
• A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed